David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Sprouts Farmers Market
SFM
$7.82B
| $24.4M | 0.03% |
1,000,878
+37,834
| +4% | +$802K |
|
577
CALL
JD.com
JD
$39.4B
| $24.4M | 0.03% |
588,000
-464,800
| -44% | -$18.3M |
|
578
Telus
TU
$15.6B
| $24.4M | 0.03% |
1,286,776
+542,776
| +73% | +$10M |
|
|
MNTA
579
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $24.3M | 0.03% |
1,743,766
+273,495
| +19% | +$3.7M |
|
580
Microchip Technology
MCHP
$39.7B
| $24.3M | 0.03% |
553,206
+172,478
| +45% | +$7.8M |
|
581
Rio Tinto
RIO
$171B
| $24.3M | 0.03% |
459,209
+375,454
| +448% | +$18.3M |
|
|
APC
582
CALL
DELISTED
Anadarko Petroleum
APC
| $24.3M | 0.03% |
452,900
+212,900
| +89% | +$10.5M |
|
583
Blackrock
BLK
$181B
| $24.3M | 0.03% |
47,230
| – | – |
|
584
TriNet
TNET
$3.24B
| $24.3M | 0.03% |
547,148
+105,842
| +24% | +$4.24M |
|
585
Rogers Communications
RCI
$19.5B
| $24.2M | 0.03% |
475,239
+149,518
| +46% | +$7.79M |
|
|
COHR
586
DELISTED
Coherent Inc
COHR
| $24.1M | 0.03% |
85,465
+67,369
| +372% | +$18.8M |
|
|
DRE
587
DELISTED
Duke Realty Corp.
DRE
| $24.1M | 0.03% |
885,082
+449,452
| +103% | +$12.8M |
|
|
TWX
588
CALL
DELISTED
Time Warner Inc
TWX
| $24M | 0.03% |
262,900
+222,900
| +557% | +$21.1M |
|
589
Zurn Elkay Water Solutions
ZWS
$8.09B
| $24M | 0.03% |
1,917,491
+113,165
| +6% | +$1.36M |
|
590
PUT
Pfizer
PFE
$159B
| $24M | 0.03% |
698,170
-29,195
| -4% | -$995K |
|
591
Atlassian
TEAM
$43.5B
| $24M | 0.03% |
526,422
+347,794
| +195% | +$16.2M |
|
592
Unum
UNM
$14.1B
| $23.7M | 0.03% |
432,372
+341,465
| +376% | +$18.3M |
|
593
CALL
AbbVie
ABBV
$466B
| $23.7M | 0.03% |
244,900
-188,100
| -43% | -$17.7M |
|
594
PUT
Sherwin-Williams
SHW
$84.2B
| $23.7M | 0.03% |
173,100
+54,900
| +46% | +$7.22M |
|
595
Goodyear
GT
$1.72B
| $23.7M | 0.03% |
732,024
-228,503
| -24% | -$7.26M |
|
596
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.29B
| $23.7M | 0.03% |
800,640
+1,640
| +0.2% | +$48.4K |
|
597
Jazz Pharmaceuticals
JAZZ
$16.3B
| $23.6M | 0.03% |
175,516
+136,557
| +351% | +$18.9M |
|
598
Ambarella
AMBA
$3.09B
| $23.6M | 0.03% |
402,159
+223,606
| +125% | +$12.4M |
|
599
CALL
Walmart Inc
WMT
$834B
| $23.6M | 0.03% |
717,000
-107,400
| -13% | -$3.29M |
|
600
CALL
American Airlines Group
AAL
$9.09B
| $23.5M | 0.03% |
451,500
+112,500
| +33% | +$5.61M |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.